HCC Pathogenesis In NASH & The Impact Of Fibrosis (Hepatocellular Carcinoma) | Dr Scott L. Friedman скачать в хорошем качестве

HCC Pathogenesis In NASH & The Impact Of Fibrosis (Hepatocellular Carcinoma) | Dr Scott L. Friedman

Dr Scott L. Friedman talks about HCC (Hepatocellular Carcinoma) pathogenesis in NASH (Nonalcoholic Steatohepatitis) and the impact of fibrosis. ⚕️Dr. Scott L. Friedman is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, at the Icahn School of Medicine at Mount Sinai. This video is adapted from a lecture Dr Scott L. Friedman gave at the Paris NASH meeting and illustrates the highlights of that topic in this video. 0:00 Intro 0:36 Overview 1:01 HCC/Fibrosis in NASH - Epidemiology and clinical features 4:50 HCC mechanisms that are unique to NAFLD and not fibrosis-dependent 14:03 Mechanisms linking fibrosis to NASH-HCC 22:23 Nash-HCC + Fibrosis - Summary ------------------------------------------------------------- The PanNASH™ initiative aims to increase awareness and disseminate knowledge related to NASH (non-alcoholic steatohepatitis) as a multisystem disease with a focus on PPAR agonists among the scientific and clinical community, patients and other key stakeholders within the healthcare system, thus improving the lives of millions of patients worldwide. Learn as much as possible to seek quality for better NASH care. ✉ SIGN-UP to receive our newsletter and/or our free science magazine: https://pannash.org/newsletter/ FOLLOW US: LinkedIn:   / pannash-initiative   Twitter:   / pannash_init   CHECK OUT FOR FREE MORE EDUCATIONAL NASH VIDEO content obtained from expert doctors worldwide: https://pannash.org/videos/ LAST COMMENTED ARTICLES: https://pannash.org/commented-articles/